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Tumor necrosis factor (TNF-a) triggers biphasic activation of the NF-nB transcriptional regulator. This process consists of an initial,
InBa-mediated transient phase and a later, persistent phase dependent on InBh degradation. To presumably interfere with the fulfillment
of this immunity-associated event in cells infected with the molluscum contagiosum virus (MCV), this pathogen produces the
intracellular MC159 protein. To define the mode of action of MC159, the impact of TNF-a on HEK 293T cells ectopically expressing
the MC159 protein was examined. In this regard, TNF-a-induced expression of an NF-nB-regulated luciferase reporter gene was
partially inhibited by the MC159 protein. This ability was attributed to blockage of the persistent phase of TNF-a-induced NF-nB
activation for the following reasons: (1) the initial phase of NF-nB transcriptional activation was not affected by the MC159 protein; (2)
the MC159 protein inhibited TNF-a-directed degradation of InBh, but not InBa; and (3) expression of the late NF-nB-regulated cell
genes, TNF-a and CCL2, was decreased in the presence of the MC159 protein while transcription of the early NF-nB-regulated cell
gene, CXCL1, was not altered. Previously reported MC159–RIP interactions appear to be irrelevant for the MC159 inhibitory function.
In contrast, MC159–TRAF2 associations are more relevant for inhibitory function since mutant MC159 proteins unable to bind TRAF2
also cannot inhibit TNF-mediated NF-nB activation. In vivo, the MC159 protein may act to prolong virus survival by preventing the
infected cell from responding to TNF-a, ultimately preventing the cellular production of proinflammatory and immunoattractant
molecules.
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Tumor necrosis factor-a (TNF-a) is a pluripotent cytokine
that activates the NF-nB signal transduction pathway in a
biphasic, temporal manner (Hoffmann et al., 2002; Schmidt
et al., 2003). Initially, binding of TNF-a to TNF-Receptor I
(TNF-RI) triggers TRADD (TNF-RI-Associated death
domain), RIP (receptor-interacting protein) and TRAF2
(TNF-receptor-associated factor) migration to the receptor,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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(Mitogen-activated protein kinase kinase) proteins (Chen
and Goeddel, 2002; Yang et al., 2001). The MEKK
proteins in turn activate the I kappa kinase (IKK) complex,
and the resultant complexes interact with specific InB/NF-
nB complexes (Schmidt et al., 2003). The rapid association
of MEKK3 with IKK and InBa/NF-nB complexes enables
phosphorylation and degradation of the NF-nB-associated
InBa molecule, resulting in NF-nB nuclear translocation
and subsequent transcriptional activation of NF-nB-regu-
lated genes. This transient phase is quickly terminated
because the released NF-nB induces InBa production and
nascent InBa binds to and inhibits NF-nB. However, in the
continued presence of TNF-a, MEKK2 associates with
IKK, and forms InBh/NF-nB/IKK/MEKK2 complexes.
During this persistent activation phase InBh is degraded05) 255 – 264
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the nucleus. As would be expected from this biphasic
activation, some ‘‘early’’ NF-nB-regulated genes are ex-
pressed rapidly after TNF-a treatment, while other ‘‘inter-
mediate’’ and ‘‘late’’ genes are transcribed only after
persistent incubation with TNF-a (Hoffmann et al., 2002,
2003; Zhou et al., 2003).
The MC159 product of the molluscum contagiosum
virus (MCV) was previously shown to inhibit NF-nB
activation induced by the over-expression of TNF-RI
molecules (Chaudhary et al., 1999). The goal of this study
was to determine the effect of the MC159 protein on the
transient and persistent phases of TNF-a-induced NF-nB
activation. We examined TNF-a-mediated InBa and InBh
degradation, NF-nB transcriptional activation and NF-nB-
mediated gene transcription in 293T cells ectopically
expressing the MC159 gene product. We also examined
the relationship between MC159-RIP and MC159–TRAF2
associations and their role in inhibiting TNF-a-mediated
signaling.Fig. 1. The effect of MC159 expression on TNF-a-induced NF-nB
activation. 293T cells were co-transfected with a plasmid that has a firefly
luciferase gene under the control of an NF-nB promoter (pNF-nBluc), a
plasmid with a sea pansy luciferase gene expressed constitutively (pRL-
null) and either a plasmid expressing MC159 (MC159/pCI) or empty vector
(pCI) and incubated for 24 h. (A) Transfected cells were treated with media
absent for or containing TNF-a (10 ng/ml) for 6, 12 or 24 h. Cells were
collected and lysed, and luciferase activities were measured. An asterisk (*)
indicates statistically significant inhibition of luciferase activity (P < 0.006)
in MC159/pCI-transfected cells versus pCI-transfected cells. (B) Trans-
fected cells were incubated with media containing 0–10 ng TNF-a/ml
media for 12 h. Cells were collected and lysed, and luciferase activities
were measured. Statistical significant inhibition of luciferase activity (P <
0.004) in MC159/pCI- versus pCI-transfected cells is denoted by an asterisk
(*). For all experiments, a portion of each lysate was also analyzed for
MC159 expression by probing immunoblots (IB) with anti-MC159 antisera
(see IB below each graph).Results
MC159 proteins inhibit TNF-a-induced expression of a
luciferase reporter gene
NF-nB activation induced via over-expression of death
receptors was previously shown to be inhibited by MC159
expression (Chaudhary et al., 1999). To use a model
system more closely mimicking the physiological environ-
ment, we chose to activate TNF-RI signaling events by
incubating cells with TNF-a. This system was previously
utilized to prove that MC159 inhibited death-receptor-
induced apoptosis (Bertin et al., 1997). MC159 inhibitory
function was assayed by comparing NF-nB-driven firefly
luciferase production in TNF-a-treated and untreated cells.
TNF-a-induced luciferase activity, which correlates with
NF-nB activation, was significantly lower in MC159-
expressing cells versus vector-transfected cells at all time
points tested (P < 0.006) (Fig. 1A). Luciferase activity in
MC159 expressing cells was 50, 75 and 90% lower than
pCI-transfected cells after 6, 12, and 24 h of TNF-a
treatment, respectively. MC159 protein levels were similar
in all cells, as determined by immunoblotting extracts for
the presence of MC159 (Fig. 1). In some assays, luciferase
activity was slightly increased in untreated, MC159-
expressing cells (13- to 14-fold higher) as compared to
untreated, pCI-transfected cells (Fig. 1). This activating
effect was marginal compared to TNF-a induction. The
level of luciferase activity returned to that detected in
vector-transfected cells when MC159-expressing cells were
incubated for longer times (data not shown). Luciferase
activities were also significantly lower (P < 0.004) in
MC159-expressing cells treated with either 1, 5 or 10 ng
TNF-a/ml for 12 h (Fig. 1B).
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of NF-jB transcriptional activation
To determine the mechanism of NF-nB inactivation by
MC159, NF-nB transcriptional activation (and therefore
nuclear translocation), was examined in pCI- and MC159/
pCI-transfected cells via electromobility shift assays (Fig.
2). A mobility-shifted band (indicative of active NF-nB)
was prominent when vector-transfected cells were incubated
with TNF-a for 30–90 min (Fig. 2A). The band intensity
decreased during longer TNF-a incubation times (105–120
min), and reappeared again at 150 and 210 min. Likewise, a
band with the same altered mobility was also detected when
assaying MC159-expressing cells treated with TNF-a for
30–90 min and continued to be detected until 180 min of
TNF-a treatment, indicating that MC159 did not inhibit the
initial TNF-a-induced NF-nB transcriptional activation
(Fig. 2A). The intensity of the shifted band started to
decrease at 150 min of TNF-a treatment and was
undetectable by 210 min, suggesting that MC159 inhibitedFig. 2. TNF-a-induced nuclear localization of NF-nB. 293T cells were transfected
with medium alone (‘‘C’’) or containing TNF-a (10 ng/ml) for the times indicated
sample were incubated with 32P-radiolabeled oligonucleotide containing consen
Mobility-shifted bands containing NF-nB are indicated by an asterisk (*). Analys
lane ‘‘FP.’’ (B) Nuclear extracts from untreated cells (‘‘C’’) or cells treated with TN
no antisera (‘‘ – ’’) for 10 min at room temperature before the addition of radiolabe
NF-nB complexed with radiolabeled oligonucleotide while the double asterisk (*
oligonucleotides and anti-NF-nB antisera.the later phase of TNF-induced NF-nB transcriptional
activation.
To confirm that the p65 and p50 subunits of NF-nB were
responsible for retarding the migration of the radiolabeled
oligonucleotide in these assays, extracts from TNF-a-
treated, vector-transfected cells were incubated with either
anti-p65 or anti-p50 antisera (Fig. 2B). In comparison to
samples lacking the antibodies, the NF-nB-containing band
was decreased in intensity in reactions containing either
anti-p65 or anti-p50 antisera. In general, the absence of a
super-shifted band is evidence (albeit indirect) that anti-p65
has recognized and bound to p65 proteins. Additionally, a
super-shifted band was detectable in reactions containing
anti-p50 antisera (Fig. 2B), confirming that the p50 subunit
is one of the major NF-nB species active during TNF
treatment. In contrast, anti-p52 or anti-c-Rel antisera did not
alter the mobility or change the intensity of the NF-nB-
containing band (Fig. 2B). Similar results were observed
when nuclear proteins from MC159-expressing cells were
tested (Fig. 2B), indicating that MC159 expression did notwith either pCI or MC159/pCI. At 24 h post-transfection, cells were treated
. (A) Cells were harvested and 2 Ag of nuclear-extracted proteins from each
sus NF-nB binding sites and assayed via an electromobility shift assay.
is of a reaction containing only unbound radiolabeled probe is indicated in
F-a for 30 min were pre-incubated with the indicated antibodies (‘‘Ab’’) or
led oligonucleotides. The single asterisk (*) represents the mobility-shifted
*) represents the super-shifted complex of NF-nB bound with radiolabeled
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NF-nB subunits.
The MC159 protein inhibits TNF-a-mediated IjBb
degradation, but not IjBa degradation
Results from the electromobility shift assay appeared to
contradict those from the luciferase assay: MC159 expres-
sion did not alter early TNF-a induced NF-nB transcrip-
tional activation although it decreased NF-nB-controlled
firefly luciferase expression and inhibited later phases of
TNF-a induced NF-nB transcriptional activation. Since the
two phases of TNF-a induced NF-nB activation are
differentially regulated (Schmidt et al., 2003; Thompson et
al., 1995), one hypothesis was that the MC159 protein did
not affect InBa-mediated transient NF-nB activation, but
instead inhibited the InBh-mediated persistent activation of
NF-nB.
To more accurately assess the effect of MC159 gene
expression on the transient and persistent NF-nB activation
phases, we examined cellular InBa and InBh levels,
respectively, in cells treated with TNF-a in the presence
or absence of MC159 proteins (Fig. 3). After 30 min
exposure to TNF-a, the amount of cellular InBa decreased
dramatically in both pCI- and MC159/pCI-transfected cells
(Fig. 3A). Nascent InBa protein was detected in cells
incubated with TNF-a for 60–120 min, in agreement with a
previous report (Schmidt et al., 2003).Fig. 3. InBa and InBh levels in TNF-a-treated cells. 293T cells were
transfected with either pCI or MC159/pCI. At 24 h post-transfection, cells
were incubated with media alone or media containing TNF-a (10 ng/ml) for
the indicated times. Cells were collected and lysed. Equal amount of
cytoplasmic extracts were electrophoretically separated by 12% SDS-PAGE
and analyzed by probing immunoblots with either (A) anti-InBa or (B)
anti-InBh antisera. A separate set of identical blots was incubated with anti-
MC159 and with anti-actin antibodies.TNF-a-induced InBh protein degradation occurs later
than InBa degradation (Schmidt et al., 2003; Thompson et
al., 1995). Thus, as expected, InBh levels were slightly
decreased in vector-transfected cells incubated with TNF-a
for 60 min, and was undetectable by 120 min post-treatment
(Fig. 3B). This correlates with the detection of a faint
mobility-shifted band in nuclear extracts from pCI-trans-
fected cells incubated with TNF for 150–210 min (Fig. 2A).
In contrast, InBh protein levels in MC159-expressing cells
remained constant at all times (Fig. 3B). This correlates with
the decreasing intensity of the mobility-shifted band in
nuclear extracts from MC159-transfected cells incubated
with TNF-a for 150–240 min (Fig. 2A). It should be noted
that InB protein degradation was not due to global protein
degradation being induced by TNF-a in the absence of the
MC159 protein as the relative amount of actin remained
constant in both types of transfected cells (Fig. 3).
MC159 inhibits activation of genes expressed later after
TNF-a treatment
As a result of biphasic NF-nB activation, TNF-a
induces the expression of some genes immediately, while
that of others is upregulated later (Hoffmann et al., 2002,
2003; Zhou et al., 2003). Since the MC159 protein pre-
vented InBh degradation, but did not alter InBa degrada-
tion, we hypothesized that MC159 would not affect early
gene transcription, but would decrease the activation of
genes expressed late after exposure to TNF-a. Accordingly,
we screened for the presence of mRNA from genes
previously characterized as either early or later responders
to TNF-a exposure (Hoffmann et al., 2002, 2003; Zhou
et al., 2003) by using semi-quantitative reverse tran-
scriptase PCR (RT-PCR).
The CXCL1 gene is expressed soon after TNF-a
treatment of cells (Hoffmann et al., 2002, 2003; Zhou et
al., 2003) and CXCL1 cDNAwas easily detected when pCI-
and MC159/pCI-transfected cells were treated with TNF-a
for 1 h (Fig. 4A), indicating that the CXCL1 gene had been
transcribed. GAPDH cDNA was co-amplified in each PCR
reaction, verifying that cells transcribe CXCL1 mRNA only
in response to TNF-a. After 8 h TNF-a treatment, CXCL1
cDNA was similar to the level amplified in pCI-transfected
cells treated with TNF-a for 1 h. CXCL-1 cDNA was
slightly decreased in MC159-expressing cells treated with
TNF-a for 8 h.
TNF-a and CCL-2 genes are expressed at later times
in response to TNF-a-induced NF-nB activation (Hoff-
mann et al., 2002, 2003; Zhou et al., 2003). Accordingly,
TNF-a and CCL-2 PCR products were undetectable in
vector- and MC159/pCI-transfected cells incubated with
TNF-a from 0 to 1 h, but appeared after 8 h (Figs. 4B and
C). In comparison to pCI-transfected cells, the TNF-a
amplicon was less abundant (Fig. 4B) in MC159-expressing
cells that were incubated with TNF-a for 8 h. Similarly,
CCL-2 PCR products were decreased in response to TNF-a
Fig. 5. The effect of MC159 protein expression on RIP-mediated NF-nB
activation. 293T cells were transfected with 450 ng pNF-nBluc, 50 ng
pRLnull, 0–500 ng pRIP and 1000 ng of either pCI or MC159/pCI. At 24 h
post-transfection, cells were collected and lysed, and luciferase activities
were measured. A portion of each lysate was analyzed by using
immunoblotting (‘‘IB’’). Immunoblots were probed with either anti-RIP
or anti-MC159 antisera for detection of RIP or MC159 proteins,
respectively.
Fig. 4. TNF-a-induced transcription of early and intermediate NF-nB-
regulated host cell genes. 293T cells were transfected with either plasmid
pCI or MC159/pCI. At 24 h post-transfection, cells were incubated with
media alone or media containing TNF-a (10 ng/ml). Cells were collected
and harvested after either 0, 1 or 8 h after TNF-a treatment, and RNA was
extracted and reverse transcribed. The resulting cDNA was incubated with
primers specific for the (A) CXCL1, (B) TNF-a or (C) CCL-2 genes, as
well as primers to the GAPDH housekeeping gene and subjected to PCR
amplification. PCR products were resolved on 1% agarose gel and stained
with ethidium bromide.
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samples (Fig. 4C).
The MC159 protein does not inhibit RIP-induced NF-jB
activation
The RIP accessory molecule is important in recruiting
MEKK3 to the TNF-RI complex (Blonska et al., 2004; Yang
et al., 2001), suggesting that RIP controls the early phase of
TNF-mediated NF-nB activation by specifically activating
MEKK3. Our data indicated that MC159 did not prevent the
MEKK3-regulated early phase of NF-nB activation, sug-
gesting that previously reported RIP–MC159 interactions
were not biologically relevant (Chaudhary et al., 1999). To
test this hypothesis, we assayed the ability of MC159 to
inhibit NF-nB activated by RIP over-expression. Luciferase
activity was not significantly lower when cells were co-
transfected with 500 ng of plasmid pRIP and MC159/pCI
versus pRIP and pCI (Fig. 5). Luciferase levels were higher
in MC159-expressing cells than in control cells when cells
were transfected with lower amounts of pRIP. Since MC159
over-expression alone induced luciferase activity, then
higher luciferase levels detected in MC159/pCI-pRIP co-
transfected cells were additive. As expected, MC159 protein
expression was equal in all MC159/pCI-transfected cells
and RIP expression increased as the amount of pRIP present
in transfection reactions increased (Fig. 5, immunoblots).MC159–TRAF2 binding correlates with the MC159
inhibitory function
MC159–TRAF2 interactions were also reported previ-
ously (Chaudhary et al., 1999). TRAF2 over-expression via
ectopic expression weakly induces NF-nB activation, even
when 2000 ng of a pTRAF2 plasmid is transfected into cells
(data not shown). Therefore, instead of using NF-nB
luciferase reporter assays to investigate the role of TRAF2
in the inhibitory function of MC159, we analyzed mutant
MC159 proteins missing either the first or second death
effector domain (DED) (Garvey et al., 2002a) for their
ability to (1) bind to TRAF2 molecules, and (2) inhibit
TNF-induced luciferase activity.
Cells were co-transfected with plasmid pTRAF2 and
plasmids containing either the wild type or mutated MC159
ORFs (pMC159A and pMC159B). pMC159A expresses the
MC159A mutant protein, which is missing the second DED
while pMC159B codes for the MC159B protein, which
lacks the first DED (Garvey et al., 2002a). TRAF2 proteins
were immunoprecipitated from cell lysates and the presence
of MC159 was assayed for by immunoblotting the
immunoprecipitated samples (Fig. 6A). Both the 25-kDa
wild type and 15-kDa MC159A proteins were readily
detected in immunoprecipitates. In contrast, very little
MC159B proteins associated with TRAF2. The TRAF2
Fig. 6. The effect of mutant MC159 protein expression on TRAF2 binding
and TNF-induced NF-nB activation. (A) Cells were transfected with 500 ng
pTRAF2 and 500 ng of either MC159/pCI, pMC159A or pMC159B. 24 h
later, cells were collected and lysates were incubated with either anti-
TRAF2 (TR2) or rabbit IgG (NS) as a negative control. Immunoprecipitated
samples were analyzed by using immunoblotting for MC159 proteins
(upper panel). A portion of each pre-immunoprecipitated lysate sample was
analyzed for either MC159 or TRAF2 expression by using immunoblotting
(middle and lower panels, respectively). (B) 293T cells were transfected
with 450 ng pNF-nBluc, 50 ng pRLnull, 500 ng of either pCI, MC159/pCI,
pMC159A or pMC159B for 24 h. Transfected cells were treated with media
absent for or containing 10 ng/ml TNF-a for 12 h. Cells were collected and
lysed, and luciferase activities were measured.
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possibility that the lack of MC159B–TRAF2 interactions
was due to low protein expression (Fig. 6A, middle and
lower panels). These interactions are specific, as confirmed
by the absence of wild type and mutant MC159 proteins in
immunoprecipitation reactions using a non-specific (NS)
antibody.
Next, TNF-a-induced NF-nB luciferase activity in cells
expressing the mutant MC159 proteins was compared to
cells expressing wild-type MC159 products. TNF-induced
luciferase activity in MC159A-expressing cells was approx-
imately 2.5-fold lower than pCI-transfected cells, similar to
levels in cells expressing wild-type MC159 proteins (Fig.
6B). MC159B molecule expression did not inhibit luciferase
activity since luciferase levels in pMC159B- and pCI-
transfected cells were similar (Fig. 6B).Discussion
TNF-a is a powerful proinflammatory cytokine that
mediates anti-viral effects. Many viruses, including poxvi-
ruses, inhibit TNF-a signaling to enhance survival (Hiscott
et al., 2001; Seet et al., 2003). Here, we present data that the
MCV MC159 protein prevents TNF-a-induced InBh
degradation and consequently the NF-nB transcriptional
activation and NF-nB-mediated expression of cellular genes
that are initiated later in response to TNF-a. Moreover, we
found that the MC159 protein did not prevent InBa
degradation, correlating with its inability to inhibit transient
NF-nB transcriptional activation, or inhibit the upregulation
of transcription of early host genes. Thus, MC159 appears to
utilize a novel mechanism, specifically targeting the
persistent phase of TNF-a-induced NF-nB activation to
dampen later TNF-a-mediated signaling events.
TNF-RI-mediated NF-nB activation is dependent on the
formation of a TRADD-RIP-TRAF2 signalsome that in turn
activates the IKK complex, resulting in InBa degradation and
NF-nB activation (Chen and Goeddel, 2002). Because
MC159 co-immunoprecipitates with RIP (Chaudhary et al.,
1999), it was hypothesized that MC159 interacts with this
protein to inhibit signalsome formation and subsequent
downstream NF-nB activation events (i.e., IKK activation,
InBa degradation and early NF-nB transcriptional activa-
tion). However, the expression of MC159 did not inhibit
these events (Figs. 2 and 3A), suggesting that the MC159–
RIP interactions are not biologically relevant. In support of
this idea, we observed that MC159 did not prevent NF-nB
activation induced by RIP over-expression (Fig. 5). A report
from Chan et al. (2003) showing that MC159 does not
interfere with RIP migration to the TNF–RI signalsome also
bolsters the hypothesis that previously reportedMC159–RIP
interactions are not important for MC159 inhibitory function.
MC159 possesses two DEDs (Senkevich et al., 1996).
These motifs are important for protein–protein interactions
and were originally predicted to be important for MC159 to
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proteins (Senkevich et al., 1996, 1997). Indeed, MC159–
FADD and MC159–procaspase-8 interactions were origi-
nally thought to be critical for MC159’s ability to inhibit
TNF-mediated apoptosis (Bertin et al., 1997). A more
detailed analysis of MC159 reveals that anti-apoptosis
activity does not correlate with MC159–FADD or
MC159–procaspase-8 interactions (Garvey et al., 2002b).
Similarly, we have found that RIP–MC159 interactions are
not predictive of a MC159 mechanism for inhibiting NF-nB
activation.
The MC159 protein also inhibits NF-nB activation
mediated through PKR (Gil et al., 2001) and MyD88
over-expression (data not shown). Since TRAF proteins
are critical accessory molecules common among the
PKR, Toll-like receptor and TNF-RI NF-nB activation
pathways, one likely inhibitory mechanism for the
MC159 protein is to inhibit TRAF activity. In addition
to co-immunoprecipitation data demonstrating MC159–
TRAF2 interactions (Chaudhary et al., 1999), we
observed that the mutant MC159A protein inhibited
TNF-induced NF-nB activation and associated with
TRAF2. In contrast, the mutant MC159B protein, which
did not bind TRAF2, did not inhibit TNF-induced
luciferase activity. These data implied that MC159–
TRAF2 interactions are critical for the inhibitory functionFig. 7. A model of MC159 inhibition of the TNF-RI-mediated NF-nB activation p
RIP and TRAF2. RIP activates MEKK3 to phosphorylate the IKK complex and
figure). A similar mechanism is proposed for TRAF2 and MEKK2 (right side
complexes, resulting to InBa degradation and nuclear translocation of NF-nB, ac
complexes, in contrast, phosphorylate InBh:NF-nB complexes, resulting to InBh
persistent phase of NF-nB activation. Our current model is that MC159 proteins bi
NF-nB.of MC159. Further, the MC159 cellular homolog
cFLIP(L) requires TRAF2 interactions for its NF-nB-
activating function (Kataoka and Tschopp, 2004). In light
of reports showing that RIP binds MEKK3 and RIP
over-expression activates MEKK3-dependent NF-nB
activity (Blonska et al., 2004; Yang et al., 2001), it is
tempting to speculate that TRAF proteins activate MEKK2,
triggering NF-nB. Further, we propose that MC159–TRAF2
interactions are responsible for preventing MEKK2–IKK
complex formation to prevent InBh degradation. An illus-
tration of this proposed model is shown in Fig. 7.
Alternatively, MC159 may associate directly with InBh/
NF-nB complexes, similar to the cellular nB-ras molecule
(Chen et al., 2003) to specifically prevent IKK-mediated
InBh phosphorylation.
The homologous KSHV vFLIP induces InBa phos-
phorylation and degradation (Sun et al., 2003) by binding
to the IKK-gamma subunit, thereby activating the IKK
complex (Field et al., 2003). Since MC159–IKK inter-
actions were not detected previously (Chaudhary et al.,
1999), it is unlikely that MC159 binds directly to IKK to
induce selective degradation of InBh. It is also unlikely
that MC159 binds to and inhibits specific NF-nB dimer
populations since there was no detectable difference in the
type of NF-nB subunits present in nuclei from vector-
and MC159-expressing cells treated with TNF (Fig. 2B).athway. TNF-RI activated by TNF-a recruits the adapter proteins TRADD,
activate the early phase of TNF-RI-induced NF-nB activation (left side of
of figure). MEKK3–IKK complexes in turn phosphorylate InBa/NF-nB
tivating the early, but transient, phase of NF-nB activation. MEKK2–IKK
degradation and nuclear translocation of NF-nB, activating delayed, but
nd TRAF2 to specifically inhibit the InBh-mediated persistent activation of
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the same NF-nB dimers for expression (Hoffmann et al.,
2003) but are affected differentially by the MC159 protein
(Fig. 4). The effect of MC159 expression on other cellu-
lar genes expressed early or late after TNF-a treatment
will also give further insight into MC159’s molecular
mechanism.
These studies were performed in the human 293T cell
line. Although these cells are not the natural host for an
MCV infection, we purposefully chose to use this cell line
as a model system because it expresses high TNF-RI and
low TNF-RII molecules. Future studies determining the
effect of MC159 expression on TNF-a-mediated signaling
in either transformed or primary keratinocytes are
planned. Keratinocytes are the exclusive host cells for
MCV infection. These cells produce TNF-a, a cytokine
that induces macrophage migration, in response to a wide
variety of stimuli. MCV-infected lesions are devoid of
immune cells (Viac and Chardonnet, 1990) suggesting that
chemoattractant molecules are absent at MCV infection
sites. We show here that MC159 reduces the transcription
of the CCL-2 gene, a monocyte chemoattractant protein,
and TNF-a, which induces macrophage migration to sites
of infection. MC159 protein expression may selectively
inhibit the TNF-a-mediated production of specific chemo-
attractive molecules, resulting in localized immunosup-
pression and the characteristic benign MCV lesions.
Future studies that detect mRNA and protein levels of
these and other chemoattractant molecules in MC159-
expressing cells over time will give great insight into the
importance of MC159 expression during an MCV
infection.Materials and methods
Reagents
For all experiments, human embryonic kidney 293T cells
(ATCC) were transiently transfected with the Fugene 6
transfection reagent (Roche). Recombinant human TNF-a
(Roche) was used to activate NF-nB. Plasmids MC159/pCI
and pCI and anti-MC159 antibody have been described
previously (Shisler and Moss, 2001).
Luciferase assays
Luciferase assays were carried out as described pre-
viously (Shisler and Jin, 2004). 293T cells were co-
transfected with 450 ng pNF-nBluc (Stratagene), 50 ng
pRL-null (Promega) and either plasmid MC159/pCI or pCI.
The pMC159A and pMC159B plasmids were a gift from
Dr. Jeff Cohen (National Institutes of Health, Bethesda,
MD) and have been described previously (Garvey et al.,
2002a). pNF-nBluc contains the firefly luciferase gene
under the control of an NF-nB-specific promoter. pRL-nullexpresses constitutively low levels of the sea pansy
luciferase and is used to define transfection efficiencies.
At 24 h post-transfection, cells were incubated with media
containing TNF-a at the concentrations and times indicated
in the figure legends. In some assays, cells were transfected
with the pRIP plasmid (a gift from Dr. Preet Chaudhary,
University of Texas Southwestern Medical Center). For
these experiments, RIP over-expression was used instead of
TNF-a to induce NF-nB activation. Cells were lysed and
firefly and sea pansy luciferase activities of whole cell
extracts were assayed by using the Dual Luciferase Reporter
Assay System (Promega). Each experiment was performed
in triplicate and firefly luciferase activity was divided by the
sea pansy luciferase activity for each experimental point to
normalize transfection efficiencies. The resultant ratios were
normalized to that of untreated, pCI-transfected cells, whose
value was taken as one.
Immunoblotting
Immunoblotting for cytoplasmic InB has been previously
described (Shisler and Jin, 2004). 293T cells were trans-
fected with 1 Ag of either plasmid MC159/pCI or pCI. At 24
h post-transfection, cells were incubated in media alone or
media containing TNF-a (10 ng/ml). At varying times after
TNF-a treatment, cells were harvested, collected by
centrifugation and lysed in CE buffer at 4 -C for 5 min.
Lysates were centrifuged briefly and supernatants contain-
ing cytoplasmic extracted proteins were assayed for protein
concentration using the BCA Protein Assay Kit (Pierce).
Equal amount of protein from each sample (25 Ag) was
resolved by 12% SDS-PAGE and transferred to a PVDF
membrane. Blots were incubated with the indicated primary
antibody and then incubated with a horseradish peroxidase-
conjugated secondary antibody (Pierce). Blots were devel-
oped using the Supersignal West Pico system (Pierce). The
anti-InBa and anti-InBh antibodies were purchased from
Santa Cruz Biotechnology, and anti-actin antibody was
purchased from Sigma.
In some experiments, cells were co-transfected with
plasmid pTRAF2 (Dr. Carl Ware, La Jolla Institute for
Allergy and Immunology) and eitherMC159/pCI, pMC159A
or pMC159B. At 24 h post-transfection, cells were collected
and lysates were incubated with Protein A-Sepharose beads
(Amersham) and either anti-TRAF2 antisera (Santa Cruz
Biotechnology) or rabbit IgG for 1 h at 4 -C while rocking.
Beads were collected by centrifugation, washed and analyzed
for the presence of MC159 by immunoblotting.
Electromobility shift assay (EMSA)
293T cells were transfected with one Ag of either plasmid
MC159/pCI or pCI. At 24 h post-transfection, cells were
incubated in media absent for or containing TNF-a (10 ng/
ml). At the times indicated, cells were harvested and collected
by centrifugation, and nuclear proteins were extracted as
L.E. Murao, J.L. Shisler / Virology 340 (2005) 255–264 263described previously (Oie and Pickup, 2001). Protein
concentrations of nuclear extracted samples were quantified
using the BCA Protein Assay Kit. Two Ag of each extract was
incubated with 1.75 pmol of 32P-labeled NF-nB double
stranded oligonucleotide (5V-AGTTGAGGGGACTTTCC-
CAGGC-3V)(Promega) in 1X binding buffer as instructed in
the Gel Shift Assay System (Promega). Reactions were
resolved on a 6% acrylamide DNA retardation gel (Invi-
trogen) under non-denaturing conditions. The gel was dried
on filter paper and exposed to a phosphorimager plate. For
some reactions, nuclear extracted proteins were incubated
with either anti-p65, anti-p50, anti-p52 or anti-cRel antisera
(Santa Cruz Biotechnology) for 10 min at room temperature
before the addition of radiolabeled probe to each reaction.
Reverse transcriptase PCR
293T cells were transfected with 1 Ag of either plasmid
MC159/pCI or empty vector. At 24 h post-transfection,
cells were incubated with either media alone or media
containing TNF-a (10 ng/ml). Cells were harvested and
lysed after 0, 1 and 8 h. RNA was harvested using the
RNeasy kit (Qiagen). Two Ag of total RNA was incubated
with 0.5 Ag oligo(dT)15 primer (Promega) and reverse
transcribed at 42 -C using ImProm-II reverse transcriptase
(Promega). One Al of the reverse transcription product was
PCR amplified by incubating cDNA with 0.2 AM primers
specific for either the CXCL1 (5V-ATGGCCCGCGCTG-
CTCTCTCC-3V and 5V-GTTGGATTTGTCACTGTTCAG-
3V), CCL-2 (5V-GCCTCCAGCATGAAAGTCTC-3V and
5V-GCTGCAGATTCTTTGGTTGT-3V) or TNF-a (5V-GAGT-
GACAAGCCTGTAGCCCATGTTGTAGCA-3V and 5V-
GGCAATGATGATCCCAAAGTAGACCTGCCCAGACT-
3V) genes. The human GAPDH gene was co-amplified in all
PCR reactions, using primers (0.02 AM) specific for the
GAPDH gene (5V-TGAAGGTCGGAGTCAACGGAT-
TTGGT-3Vand 5V-CATGTGGGCCATGAGGTCCACCAC-
3V). PCR reactions were analyzed by using agarose gel
electrophoresis and amplicons were detected by ethidium
bromide staining.Acknowledgments
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